Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study

C Deal, S Kirsch, JP Chanoine, S Lawrence… - … Open Access Journal, 2018 - cmajopen.ca
Background: Country-specific data on outcomes of treatment with recombinant human
growth hormone are lacking. We present such data for children treated with growth hormone …

Growth hormone treatment for short stature in the USA, Germany and France: 15 years of surveillance in the Genetics and Neuroendocrinology of Short-Stature …

R Pfäffle, C Land, E Schönau, PM Holterhus… - Hormone research in …, 2018 - karger.com
Abstract Background/Aims: To describe characteristics, auxological outcomes and safety in
paediatric patients with growth disorders treated with growth hormone (GH), for cohorts from …

[HTML][HTML] Comparison of response to 2-years' growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic …

PA Lee, L Sävendahl, I Oliver, M Tauber… - International journal of …, 2012 - Springer
Background Few studies have compared the response to growth hormone (GH) treatment
between indications such as isolated growth hormone deficiency (IGHD), born small for …

Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain

VS LA, LE García-Pérez - Anales de Pediatria (Barcelona, Spain …, 2015 - europepmc.org
Methods A total of 1294 children in Spain enrolled in the observational Genetics and
Neuroendocrinology of Short-stature International Study (GeNeSIS). Adverse events were …

[HTML][HTML] Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study

M Cappa, L Iughetti, S Loche, M Maghnie… - Journal of …, 2016 - Springer
Purpose We examined auxological changes in growth hormone (GH)-treated children in
Italy using data from the Italian cohort of the multinational observational Genetics and …

[PDF][PDF] Growth hormone for short children–whom should we be treating and why?

A Deodati, S Cianfarani, CJ Kelnar - JR Coll Physicians Edinb, 2012 - rcpe.ac.uk
The objective of this paper was to determine systematically the impact of growth hormone
(GH) therapy on adult height of children with (so-called)'idiopathic short stature'(ISS) using …

[HTML][HTML] Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes

D Al-Abdulrazzaq, A Al-Taiar, K Hassan… - BMC Endocrine …, 2015 - Springer
Abstract Background Recombinant Growth hormone (rGH) therapy is approved in many
countries for treatment of short stature in a number of childhood diagnoses. Despite the …

Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists

DS Hardin, J Woo, R Butsch, B Huett - Clinical Endocrinology, 2007 - Wiley Online Library
Background With the advent of several new treatment indications for recombinant hGH,
endocrinologists are being asked to make some difficult decisions regarding eligibility for …

Growth hormone therapy in children; research and practice–a review

PF Collett-Solberg, AAL Jorge… - Growth Hormone & IGF …, 2019 - Elsevier
Short stature remains the most common reason for referral to a pediatric Endocrinologist and
its management remains a challenge. One of the main controversies is the diagnosis of …

Mortality in children receiving growth hormone treatment of growth disorders: data from the Genetics and Neuroendocrinology of Short Stature International Study

CA Quigley, CJ Child, AG Zimmermann… - The Journal of …, 2017 - academic.oup.com
Context Although pediatric growth hormone (GH) treatment is generally considered safe for
approved indications, concerns have been raised regarding potential for increased risk of …